The battle to claim the continuous glucose monitor with the longest wear time continues with Dexcom Inc.’s G7 15 Day continuous glucose monitor gaining U.S. FDA clearance on April 10 for adults with ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

A research paper by scientists at The Second Affiliated Hospital of Zhejiang University School of Medicine presented the ...

The U.S. Food and Drug Administration approved DexCom, Inc.’s (NASDAQ:DXCM) Dexcom G7 15-Day Continuous Glucose Monitoring System for people over 18 with diabetes. With an overall Mean Absolute ...

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...

The 3-year-old male pug has been wearing the 'continuous glucose monitor', or CGM, sensor since he was admitted to the veterinary hospital at Parel on Friday. The CGM is a circular patch pinned on ...

Customs officials at Biju Patnaik International Airport seized nine snakes, ten turtles, and 12 monitor lizards from a passenger arriving from Thailand. The individual was questioned to determine ...

Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Diabetic retinopathy is a common complication of diabetes (including type 2 diabetes) that causes vision problems. By controlling your blood sugar, blood pressure, and cholesterol, you can reduce your ...